- Home
- YALA vs RCUS Comparison
YALA vs RCUS Comparison
Compare YALA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- RCUS
- Stock Information
- Founded
- YALA 2016
- RCUS 2015
- Country
- YALA United Arab Emirates
- RCUS United States
- Employees
- YALA N/A
- RCUS N/A
- Industry
- YALA Computer Software: Programming Data Processing
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- YALA Technology
- RCUS Health Care
- Exchange
- YALA Nasdaq
- RCUS Nasdaq
- Market Cap
- YALA 1.1B
- RCUS 906.4M
- IPO Year
- YALA 2020
- RCUS 2018
- Fundamental
- Price
- YALA $7.65
- RCUS $10.40
- Analyst Decision
- YALA
- RCUS Buy
- Analyst Count
- YALA 0
- RCUS 8
- Target Price
- YALA N/A
- RCUS $20.71
- AVG Volume (30 Days)
- YALA 836.8K
- RCUS 783.0K
- Earning Date
- YALA 08-11-2025
- RCUS 08-06-2025
- Dividend Yield
- YALA N/A
- RCUS N/A
- EPS Growth
- YALA 14.19
- RCUS N/A
- EPS
- YALA 0.81
- RCUS N/A
- Revenue
- YALA $348,190,638.00
- RCUS $262,000,000.00
- Revenue This Year
- YALA $7.52
- RCUS N/A
- Revenue Next Year
- YALA $6.88
- RCUS $28.73
- P/E Ratio
- YALA $9.62
- RCUS N/A
- Revenue Growth
- YALA 6.79
- RCUS 6.07
- 52 Week Low
- YALA $3.73
- RCUS $6.50
- 52 Week High
- YALA $9.29
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- YALA 45.09
- RCUS 63.56
- Support Level
- YALA $7.62
- RCUS $9.73
- Resistance Level
- YALA $9.10
- RCUS $10.23
- Average True Range (ATR)
- YALA 0.43
- RCUS 0.53
- MACD
- YALA -0.10
- RCUS 0.07
- Stochastic Oscillator
- YALA 11.83
- RCUS 82.11
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.